Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects

NCT04319926 ↗

Phase 1 Completed 24 enrolled Scilex Pharmaceuticals, Inc.

RandomizedCrossoverOpen-labelTreatment

Summary

An open label, randomized, two-treatment, two-period, single-dose study evaluating the product adhesion in healthy, adult subjects using ZTlido 1.8% Topical System and a generic Lidocaine Patch 5%

Timeline

Start: 2018-09-07
Primary completion: 2018-09-09
Completion: 2018-09-09

Publications

Gudin J, Webster LR, Greuber E, Vought K, Patel K, Kuritzky L. Open-Label Adhesion Performance Studies of a New Lidocaine Topical System 1.8% versus Lidocaine Patches 5% and Lidocaine Medicated Plaster 5% in Healthy Subjects. J Pain Res. 2021 Feb 23;14:513-526. doi: 10.2147/JPR.S287153. eCollection 2021.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lidocaine	Other / unclassified	1.8 %	Topical
Subject	Lidocaine	Other / unclassified	5 %	Topical

Indications

No indication recorded.